Burberry Shares Jump on Speculation of Potential Moncler Acquisition Bid Microsoft Shares Decline Historical SellOffs Have Often Preceded Recoveries ColgatePalmolive India Shifts Focus to Premium Oral Care and Digital Strategy for Next Growth Phase Ebola Survivor and Experts Share Key Lessons Speed Money and Compassion in Epidemic Response Irans Potential Tariffs on Strait of Hormuz Internet Cables Could Raise European Connectivity Costs US Stock Futures Bond Yields Fall on Reports of Updated Russian Nuclear Doctrine FUBO Q1 2026 Earnings Narrower Loss Drives Significant EPS Beat IINN Q4 2023 Earnings Narrower Loss Surprises as Inspira Advances Clinical Milestones HMR Q1 2026 Earnings EPS Beats Estimates by Over 1000 but Stock Tumbles 20 Nexalin Technology Q1 2026 Earnings EPS Misses Estimates Amidst Narrowing Losses CleanSpark CLSK Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Popular Inc Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gains Trailblazer Acquisition Corp Unit BLZRU Holds Steady Near 1021 as Trading Activity Remains Subdued Guardforce AI GFAI Nears Key Support at 046 After Modest Decline Allied Gold Corporation AAUC Gains 11 Approaches Resistance at 290 Nexstar Media Group NXST Holds Steady Near 189 as Traders Eye Key Resistance Zone Shell PLC SHEL Edges Lower in Quiet Session as Market Weighs Energy Demand Outlook General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Alliant Energy Q1 2026 Earnings EPS Beats Estimates Shares Inch Higher Figure Technology Solutions FIGR Surges 586 as Momentum Builds Toward Key Resistance SiriusPoint Ltd SPNT Declines 2 as Sector Headwinds Test Key Support AXINU Holds Steady at 1032 as Support and Resistance Levels Define Range Talphera Inc TLPH Slides 185 as Stock Tests Support Near 076 Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus First Merchants Corporation Depository Shares FRMEP Holds Steady at 2505 Key Levels in Focus NewGenIvf Warrants NIVFW Edge Lower Holding at Key 004 Support Tectonic Therapeutic TECX Slides 174 as Biotech Sector Headwinds Persist